West Pharmaceutical Services | WST - Net Income

Stock Price
302.89
Daily Change
2.70 0.90%
Monthly
12.26%
Yearly
39.81%
Q2 Forecast
296.80

West Pharmaceutical Services reported $138.8M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Align Technology USD 112.77M 22.99M Mar/2026
Avanos Medical USD 5.1M 6.4M Mar/2026
Baxter International USD -15M 1.11B Mar/2026
Becton, Dickinson and Co. USD -311M 693M Mar/2026
Cerus USD -20.92M 17.98M Dec/2024
Charles River Laboratories USD -14.84M 261.71M Mar/2026
Cooper Companies USD 130.8M 46.2M Dec/2025
Dentsply International USD -10M 136M Mar/2026
Haemonetics USD 44.74M 6.06M Dec/2025
ICU Medical USD -15.73M 12.34M Dec/2025
Insulet USD 91.1M 10.5M Mar/2026
Integra LifeSciences USD -4.62M 2.91M Mar/2026
IQVIA Holdings USD 274M 240M Mar/2026
J&J USD 5.24B 119M Mar/2026
Medtronic USD 1.14B 231M Dec/2025
Merit Medical Systems USD 41M 2.99M Mar/2026
Neogen USD -17M 1.08M Dec/2025
OraSure Technologies USD -19.29M 5.57M Dec/2025
Quidel USD -91.8M 38.9M Mar/2026
Repligen USD 8.33M 4.95M Mar/2026
Rockwell Medical USD 343K 2.07M Jun/2024
Solventum Corp USD 13M 50M Mar/2026
STAAR Surgical USD 5.21M 23.52M Mar/2026
Terumo JPY 32.65B 2.4B Dec/2025
Utah Medical Products USD 2.57M 445K Dec/2025
West Pharmaceutical Services USD 138.8M 6.7M Mar/2026